Most recently, there has been a shift in focus towards recognising sub-groups of individuals with glucose intolerance ranging from pre-diabetes to overt type 2 diabetes with their respective risk of developing complications, based on their beta-cell function and insulin sensitivity [19–21]. The gene discussed is INS; the disease is type 2 diabetes mellitus.